相关实验视频

Updated: Jul 4, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

从将基因组测序转化为临床例行中的教训:了解诊断管道的准确性

Joohyun Park¹, Marc Sturm¹, Olga Seibel-Kelemen¹

¹Institute of Medical Genetics and Applied Genomics, University of Tübingen, 72076 Tübingen, Germany.

|January 26, 2024

概括

基因组测序 (GS) 通过检测整个基因组的遗传变异,为诊断罕见疾病提供了强大的工具. 我们的研究确立了GS作为临床实践中各种遗传疾病的可靠,一线诊断方法.

科学领域:

遗传学遗传学是一个
基因组医学是基因组医学.
临床诊断临床诊断临床诊断

背景情况:

基因组测序 (GS) 可以全面检测遗传变异.
GS为人类遗传研究和临床应用提供了重大机会.
之前的研究强调了GS在变体发现和临床实用性方面的优势.

研究的目的:

实施和验证基因组测序作为罕见疾病的第一线诊断测试.
建立GS作为诊断广泛遗传疾病的可靠方法.
报告验证测序管道的过程和GS的临床实施.

主要方法:

实施基因组测序作为最初的遗传测试方法.
对测序分析管道的诊断准确性的验证.
将GS纳入常规临床实践,用于诊断遗传疾病.

主要成果:

GS成功地确定了整个基因组中的遗传变异,用于诊断罕见疾病.
已建立的GS协议证明了可靠的诊断准确性.
临床实施GS证明对广泛的遗传疾病有效.

结论:

基因组测序是罕见和遗传性疾病的高效一线诊断工具.
验证和实施GS提高了临床环境中的诊断能力.
GS提供了一种全面的诊断遗传疾病的方法,推进了基因组医学.

关键词:

遗传诊断遗传诊断遗传诊断是一个基因组测序是指对基因组进行测序.分子诊断分子诊断分子诊断

更多相关视频

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

相关概念视频

Improving Translational Accuracy

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....